Ocay, Marcelo .

HRN: 19-73-35  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/31/2024
09/07/2024
IV
1.5 G
Q8
Cellulitis
Waiting Final Action 
08/31/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/31/2024
09/07/2024
IV
600
Q8
Cellulitis
Waiting Final Action 
09/01/2024
CEFTRIAXONE 1G (VIAL)
09/01/2024
09/07/2024
IV
2g
OD
Cellulitis, Right Leg
Waiting Final Action 
09/04/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/04/2024
09/11/2024
IVT
4.5g
Q8
Cellulitus, Right Leg
Waiting Final Action 
09/07/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/07/2024
09/13/2024
IVT
600mg
Q8
Cellulitis R Leg
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: